Limited User Release of the Company's Next-Generation InSet® Glenoid Implant Follows Successful Completion of First Surgical Case . GRAND RAPIDS, Mich., Oct. 8, 2026 // ...
In his latest research note, analyst Daniel Major confirms his recommendation. The broker UBS is keeping its Neutral rating. The target price is unchanged at GBX 7400.
Stock markets finally stalled on Wednesday and early Thursday as the bond crunch ground on, with the latest Federal Reserve minutes showing most policymakers in September saw more interest rate rises ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results